Home > Insider Trading > Filing (0001140361-15-037183)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1472091	Edge Therapeutics Inc.	EDGE	Pharmaceutical Preparations (2834)	264231384

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1560685	J. Andrew Einhorn	200 Connell Drive, Suite 1600 Berkeley Heights NJ 07922	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-10-06	10,443	$0.00	10,443	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	4,747	$0.00	15,190	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	24,089	$0.00	39,279	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	2,377	$6.79	41,656	No	4	J	Direct
Common Stock	Acquisiton	2015-10-06	15,720	$0.00	15,720	No	4	C	Indirect	By Harpua, LLC
Common Stock	Acquisiton	2015-10-06	21,221	$0.00	36,941	No	4	C	Indirect	By Harpua, LLC
Common Stock	Acquisiton	2015-10-06	45,000	$11.00	81,941	No	4	P	Indirect	By Harpua, LLC
Common Stock	Acquisiton	2015-10-06	1,651	$7.75	83,592	No	4	J	Indirect	By Harpua, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	J	Direct
No	4	C	Indirect	By Harpua, LLC
No	4	C	Indirect	By Harpua, LLC
No	4	P	Indirect	By Harpua, LLC
No	4	J	Indirect	By Harpua, LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B-1 Convertible Preferred Stock	Disposition	2015-10-06	14,286	$0.00	10,443	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2015-10-06	6,494	$0.00	4,747	$0.00
Common Stock	Series C-1 Convertible Preferred Stock	Disposition	2015-10-06	32,956	$0.00	24,089	$0.00
Common Stock	Series C-1 Convertible Preferred Stock	Disposition	2015-10-06	21,506	$0.00	15,720	$0.00
Common Stock	Series C-2 Convertible Preferred Stock	Disposition	2015-10-06	29,032	$0.00	21,221	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The convertible preferred stock converted into the Issuer's common stock at a conversion ratio, as adjusted to give effect to the Issuer's 1-for-1.3681 reverse stock split effected on September 21, 2015, of one share of common stock for every 1.3681 shares of preferred stock immediately prior to the closing of the Issuer's initial public offering of common stock, and had no expiration date.
The Reporting Person is the sole managing member of Harpua, LLC and may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
The Reporting Person received a total of 2,377 shares of the Issuer's common stock which represented a payment-in-kind dividend on 39,450 shares of the Issuer's convertible preferred stock owned at the time of the dividend payment date.
Harpua, LLC received a total of 1,651 shares of the Issuer's common stock which represented a payment-in-kind dividend on 50,538 shares of the Issuer's convertible preferred stock owned at the time of the dividend payment date. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.